WO1994009797A1 - Compound for the biological stimulation and correction of the phenotype of an organism and a process for producing the same - Google Patents
Compound for the biological stimulation and correction of the phenotype of an organism and a process for producing the same Download PDFInfo
- Publication number
- WO1994009797A1 WO1994009797A1 PCT/RU1993/000189 RU9300189W WO9409797A1 WO 1994009797 A1 WO1994009797 A1 WO 1994009797A1 RU 9300189 W RU9300189 W RU 9300189W WO 9409797 A1 WO9409797 A1 WO 9409797A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fact
- salt
- small
- sized
- sugar
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/08—Mineral waters; Sea water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
Definitions
- ⁇ azvanny s ⁇ s ⁇ av m ⁇ zhe ⁇ by ⁇ shi ⁇ is ⁇ lz ⁇ van in nauchn ⁇ y and ⁇ a ⁇ iches ⁇ y ⁇ ab ⁇ e in ⁇ m including nauchn ⁇ y - ⁇ mu ⁇ agenezu 10 ⁇ ganizm ⁇ v, and ⁇ a ⁇ iches ⁇ y - to treat ⁇ azlichny ⁇ zab ⁇ le- vany zhiv ⁇ ny ⁇ and chel ⁇ ve ⁇ a, ⁇ a ⁇ i ⁇ , ⁇ a ⁇ all ⁇ etsiya, ⁇ n ⁇ l ⁇ gi- ches ⁇ ie zab ⁇ levaniya shi ⁇ vidn ⁇ y gland zhelud ⁇ chn ⁇ enteric tract, kidney and urinary tracts, women and men’s land plots.
- the product is made up of chemically related components:
- the therapeutic component is acceptable, which can be activated actively by the external source of energy (visible, ultra-radiation or radiation generation)
- the therapeutic component is suitable for linking components 1 and 2.
- This product is a multi-component, i.e. In fact, 35 garlic is made up of drugs and has no effect on the hereditary structure of the organism.
- a well-known healing agent (511, ⁇ , 1553134), containing sal-alginic acid, antisynthesis and saline, is a quick-release medicine. - £ - Keeps the following components at a weight ratio of ./%:
- the second part contains the following components in relation to weight, wt /%:
- This medium does not affect the hereditary structure of the organism.
- the method of electrical stimulation of arterial cells is known (115, ⁇ , 4487834). The method is concluded in that they only allow the external electric drive to be switched on when the electrical circuit is switched off.
- the electric field is equipped with a frequency of 60
- a method for correcting the biological system has been known ( ⁇ , ⁇ 1, 053505685).
- the method is distinguished by the fact that it is not necessary for the treatment of live, human and vegetative biological systems of any type of abnormalities.
- the latter induces the hybridization of cellular walls in the presence of radiological effects, for example, radiation, radiation emitted
- gene mutations become targeted, selectable, or selectable depending on the type of radiation, the mixing of two or a small amount of radiation is emitted.
- the methods of treating various diseases with the help of various radiation are known.
- - 3 The method of treating patients with chronic ischemic heart disease is known (5 ⁇ , ⁇ 1 1537276).
- phenotypic is a property of all the attributes and properties of an organism that is inherently disintegrated
- habitat means the impact on the patient changes (or disruptions), are not affected by the In general, the function of the organismism is
- the basic task of the invention was to create such a system for biological stimulation and compartmentalization of the ransom of the Russian Federation, which would be in our possession.
- P ⁇ s ⁇ avlennaya task ⁇ eshae ⁇ sya ⁇ em, ch ⁇ ' ⁇ edlagae ⁇ sya ⁇ a ⁇ y s ⁇ s ⁇ av, ⁇ b ⁇ ab ⁇ anny external is ⁇ chni ⁇ m ene ⁇ gii, s ⁇ de ⁇ zhalshy 5 ⁇ ischevye ⁇ du ⁇ y and imenn ⁇ v ⁇ dny ⁇ as ⁇ v ⁇ ⁇ va ⁇ enn ⁇ y s ⁇ li and sa ⁇ a ⁇ a ⁇ liches ⁇ ve in g / l: s ⁇ l 1-400, 1-3000 sa ⁇ a ⁇ .
- such a composition a short-term feedstock, contains a source of salt and sugar in the quantity, g / l: sea salt 1-400, sugar 1-3000. 10 It is proposed that such a composition, in addition to the specified components, honey is added in quantities of 1-6000 g / l.
- the product as a part of the supplement may contain chlorinated or consumable potassium in the amount of 1-320 g / l.
- the proposed composition may be included in the quality of the additive, calcium chloride or calcium carbide in the amount of 1-80 g / l. 20 The proposed composition may be included in the amount of the additive, or magnesium carbide in the amount of 1-5 g / l.
- the proposed composition may be included as a supplement for sea salt in quantities of 1-320 g / l.
- the proposed composition may contain an additive of 25 mixtures of the indicated compounds in the amount of 2-320 g / l.
- the proposed composition may contain microelements in the form of copper or manganese, copper, manganese, molybdenum, iron, calcium, nickel in a quantity of 1-4 g / l.
- P ⁇ s ⁇ avlennaya task ⁇ eshae ⁇ sya ⁇ a ⁇ zhe s ⁇ s ⁇ b ⁇ m ⁇ b ⁇ ab ⁇ i 30 s ⁇ s ⁇ ava external is ⁇ chni ⁇ m ene ⁇ gii and imenn ⁇ ⁇ em, ch ⁇ s ⁇ s ⁇ av ⁇ b ⁇ aba ⁇ yvayu ⁇ ele ⁇ iches ⁇ im ⁇ m dli ⁇ eln ⁇ s ⁇ yu im ⁇ uls ⁇ v ⁇ 10 "8 d ⁇ 1 with ⁇ u ⁇ izn ⁇ y ⁇ e ⁇ edneg ⁇ ⁇ n ⁇ a ⁇ na ⁇ yazheniyu 1 * 10 ⁇ 8 * -1 October 13 ⁇ / s and the pulse width of the 1st to 4th and the voltage of the electric field between the electrons is 10 ⁇ / cm - 35 9 * 10 4 ⁇ / cm.
- the electrical current can be converted into magnetic, electrical, magnetic or acoustic pulses.
- BASIS OF BASIS INCLUDES SUCH FOOD PRODUCTS, AS SALT, SUGAR AND HONEY.
- One of the components of these components, processed as mentioned above, is able to interact with various ug or gambling of an organism.
- salvage may be replaced by a young person, this is caused by the inability to increase the rate of treatment of the disease.
- the material content of the equipment is subject to the following reasons: the upper limit of salt and
- the external food additive (320 g / l) makes up 80% of the maximum salt content, since there is no further loss of income.
- the upper limit is in the composition for calcium is limited to 80 g / l, for magnesium - 8 g / l, for microelements -
- the electrical current has passed through the inverters to magnetic, electrical, light or acoustic impulses.
- the method of processing the electrical components of the machine 7 There is a simple processing procedure, the most important is the convenience of the impulse group.
- the increase in voltage is the same as the pulse voltage, ⁇ / s. 0 this parameter for 5 determines the level of information transmitted to the battery, i.e. whether the strings of an organism of the country will accept information on the hereditary level, or on the physiological level.
- Impulse durability is a dimensionless parameter, which is included in the ratio of the duration of the transition (the sum of the duration
- the method of acquiring the system is as follows. ⁇ the container is loaded with ingredients for the selected product (in any mixture): salt or sea salt, sugar, in the case of food - honey and food
- the uro-organisms were housed, as in the case of illnesses and infusions, and in others, in the case of the treatment of illnesses, there was no need to relax the body.
- table 1 we show the contents of the table in the following, and the following.
- Table 1 Compositions, quantities of components.
- a working cuvette was added with 0.1 ml of composition ⁇ 7, in which they laid the information for a complete disruption of the carriage. There was observed the development of two gaseous explosions, which rapidly increased-5 were observed in the size before the complete disruption of the plugs of the plug-in-the-receiver.
- the cuvette was supplemented with 0.1 ml of the ⁇ 7 solution, which was not prepared in the indicated modes, and the inlet plug-in used this method for the sys- tem.
- Example 5 0 Sugar food digestion survived for 14 days, after which the process of fermentation was prevented. Then in the factory we added 50% of the initial quantity of sugar, but the original process of disinfection was not taken into account, since the shipments were not in business.
- Example 7 The solution was added 50 ml (5 per 1 liter of the burned solution) composition ⁇ 14. Friends began to function, and the process of friendship was continued to complete the processing of sugar.
- Example 6 Wheat grains were soaked for 6 hours in a 10% crop. - 12 - Composition ⁇ 14, a direct one-time fresh grain was soaked for 6 hours in pure water, after which it was planted in the ground. It has been established that the grains are able to grow from 10 to 80%, while the growth rate of the stem grows 1.9 times as compared to the 5th ground.
- Example 7 Example 7
- Composition ⁇ 2 was bought in the dog house.
- the dog German sheep
- aged 1 year became ill with allopecia;
- the last occurrence of the alopecia has appeared on spots of 100-200 cm 2 , which has turned blue.
- the blue color disappeared after a week of lubrication - after a week it was found to be 1 cm longer, after a week it was Example 8.
- 5 Bolshoi D. city of ⁇ izhnevar ⁇ tivsk
- 10 years old with a diagnosis of pulmonary sinus during the course of the course of treatment, was treated in the center of the city of Leningrad and Leningrad.
- compositions ⁇ 6 were used for treatment.
- Za ⁇ em che ⁇ ez 10 days was nacha ⁇ v ⁇ y ⁇ u ⁇ s by direct treatment ⁇ edlagae- s ⁇ s ⁇ av ⁇ m ⁇ 4, and ⁇ echenie e ⁇ g ⁇ ⁇ u ⁇ sa (10 days) 80 ml b ⁇ ln ⁇ y ⁇ inyal s ⁇ s ⁇ ava, ⁇ sle cheg ⁇ was ⁇ luchena ⁇ l ⁇ zhi ⁇ elnaya dinami ⁇ a, ⁇ ishli in n ⁇ mu ⁇ gany zhelud ⁇ chn ⁇ - ⁇ ishechn ⁇ g ⁇ ⁇ a ⁇ a 0 v ⁇ ss ⁇ an ⁇ vilas ⁇ ech, the paralich of extremities and other countries disappeared.
- the current treatment is ongoing.
- Example 9 The current treatment is ongoing.
- Example 10 (may move his legs), the case disappeared. Treatment is continued with new formulations. Example 10.
- B ⁇ lnaya was na ⁇ avlena on sim ⁇ ma- ⁇ iches ⁇ e treatment ⁇ sle cheg ⁇ ⁇ b ⁇ a ⁇ ilas' with ⁇ sb ⁇ y ⁇ ves ⁇ i ⁇ u ⁇ s treatment ⁇ edlagaemymi s ⁇ s ⁇ avami.
- the composition of the compounds was
- a failure in the group means the absence of analysis or the absence of a component. 5
- the proposed products can be used to treat leukemia leukemia.
- the proposed system can be widely used in the first 0 scientific and practical work in biology, medicine and medicine.
- the proposed system can be used for mutagenesis of organisms, changes in their phenotypes and inherited structure. Seed management by planting 5 seeds results in increased yield and seed tolerance due to different diseases.
- veterinary infections it may be used to treat diseases of the livestock, in particular, such as allotherapy.
- ⁇ medicine - for the treatment of human diseases such as - 17 - how is the allopecia, the oncological diseases of the thyroid gland, the gastrointestinal tract, the liver and the urinary tract, the male and female cancers?
- the proposed system may also be used for protection and 5 stimulation of the human body, in particular, in the resident.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Alternative & Traditional Medicine (AREA)
- Hematology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT93919734T ATE207363T1 (de) | 1992-10-30 | 1993-08-09 | Verbindung zur biologischen stimulation und korrektur des phenotyps eines organismus und verfahren für ihre herstellung |
CA002127114A CA2127114C (en) | 1992-10-30 | 1993-08-09 | A composition for the biological stimulation and correction of the phenotype of an organism and a method for treating the same |
JP6510936A JPH07502764A (ja) | 1992-10-30 | 1993-08-09 | 生物の表現型を生物学的に刺激しかつ補正する組成物およびそれを処理する方法 |
DE69331005T DE69331005T2 (de) | 1992-10-30 | 1993-08-09 | Verbindung zur biologischen stimulation und korrektur des phenotyps eines organismus und verfahren für ihre herstellung |
DK93919734T DK0633027T3 (da) | 1992-10-30 | 1993-08-09 | Forbindelse til biologisk stimulation og korrektion af fænotypen af en organisme og en fremgangsmåde til fremstilling af samme |
EP93919734A EP0633027B1 (en) | 1992-10-30 | 1993-08-09 | Compound for the biological stimulation and correction of the phenotype of an organism and a process for producing the same |
KR1019940702303A KR100301340B1 (ko) | 1992-10-30 | 1993-08-09 | 생물체 표현형의 생물학적 자극및 교정을 위한 조성물 그리고 이것의 처리방법 |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU92003081/14 | 1992-10-30 | ||
RU9292003081A RU2093180C1 (ru) | 1992-10-30 | 1992-10-30 | Состав для биологической стимуляции организма и способ его обработки |
RU9292005267A RU2093181C1 (ru) | 1992-11-10 | 1992-11-10 | Состав для биологической стимуляции организма |
RU92005267/14 | 1992-11-10 | ||
RU9393008264A RU2093182C1 (ru) | 1993-02-15 | 1993-02-15 | Состав для биологической стимуляции организма |
RU93008264/14 | 1993-02-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1994009797A1 true WO1994009797A1 (en) | 1994-05-11 |
Family
ID=27354124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/RU1993/000189 WO1994009797A1 (en) | 1992-10-30 | 1993-08-09 | Compound for the biological stimulation and correction of the phenotype of an organism and a process for producing the same |
Country Status (7)
Country | Link |
---|---|
JP (1) | JPH07502764A (da) |
KR (1) | KR100301340B1 (da) |
DE (1) | DE69331005T2 (da) |
DK (1) | DK0633027T3 (da) |
ES (1) | ES2164668T3 (da) |
PT (1) | PT633027E (da) |
WO (1) | WO1994009797A1 (da) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000078349A1 (fr) * | 1999-06-18 | 2000-12-28 | Pascal Berdal | Procede pour l'obtention de produits ayant des effets benefiques |
FR2800575A1 (fr) * | 1999-11-08 | 2001-05-11 | Pascal Berdal | Procede pour preparer des aliments et des complements alimentaires ayant des effets sur la sante |
WO2005014019A1 (fr) * | 2003-08-07 | 2005-02-17 | Gennadij Alexandrovich Markov | Composition therapeutique et prophylactique de markov |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102548082B1 (ko) | 2020-11-26 | 2023-06-26 | 한국화학연구원 | 기상 증착을 이용한 고밀도의 균일한 나노 입자 합성 방법 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2477418A1 (fr) * | 1979-12-28 | 1981-09-11 | Kropp Werner | Procede de fabrication de medicaments et de produits pour rendre inoffensifs des microorganismes |
DE3028084A1 (de) * | 1980-07-04 | 1982-01-28 | Franco Donadelli | Waessrige loesung von extrakten aus tierischen geweben mit elektrochemischer behandlung fuer die steigerung der metabolischen vorgaenge der epithele |
WO1986000228A1 (en) * | 1984-06-22 | 1986-01-16 | Veech Richard L | Electrolyte solutions containing polyanionic materials |
EP0330800A1 (en) * | 1984-07-03 | 1989-09-06 | Schering Aktiengesellschaft | A method for affecting intracellular and extracellular electric and magnetic dipoles |
WO1989010746A2 (en) * | 1988-05-02 | 1989-11-16 | Cryomedical Sciences Inc. | Blood substitute |
FR2640510A1 (fr) * | 1988-12-20 | 1990-06-22 | Therabion Sa Laboratoires | Oligo-elements actives, leur procede de preparation et les compositions les renfermant, utiles pour la sante |
WO1992018136A1 (en) * | 1991-04-19 | 1992-10-29 | Biotime, Inc. | Blood substitutes and organ preservative solutions |
US5188738A (en) * | 1990-08-06 | 1993-02-23 | Steven Kaali | Alternating current supplied electrically conductive method and system for treatment of blood and/or other body fluids and/or synthetic fluids with electric forces |
-
1993
- 1993-08-09 ES ES93919734T patent/ES2164668T3/es not_active Expired - Lifetime
- 1993-08-09 PT PT93919734T patent/PT633027E/pt unknown
- 1993-08-09 DK DK93919734T patent/DK0633027T3/da active
- 1993-08-09 WO PCT/RU1993/000189 patent/WO1994009797A1/ru active IP Right Grant
- 1993-08-09 DE DE69331005T patent/DE69331005T2/de not_active Expired - Fee Related
- 1993-08-09 KR KR1019940702303A patent/KR100301340B1/ko not_active IP Right Cessation
- 1993-08-09 JP JP6510936A patent/JPH07502764A/ja active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2477418A1 (fr) * | 1979-12-28 | 1981-09-11 | Kropp Werner | Procede de fabrication de medicaments et de produits pour rendre inoffensifs des microorganismes |
DE3028084A1 (de) * | 1980-07-04 | 1982-01-28 | Franco Donadelli | Waessrige loesung von extrakten aus tierischen geweben mit elektrochemischer behandlung fuer die steigerung der metabolischen vorgaenge der epithele |
WO1986000228A1 (en) * | 1984-06-22 | 1986-01-16 | Veech Richard L | Electrolyte solutions containing polyanionic materials |
EP0330800A1 (en) * | 1984-07-03 | 1989-09-06 | Schering Aktiengesellschaft | A method for affecting intracellular and extracellular electric and magnetic dipoles |
WO1989010746A2 (en) * | 1988-05-02 | 1989-11-16 | Cryomedical Sciences Inc. | Blood substitute |
FR2640510A1 (fr) * | 1988-12-20 | 1990-06-22 | Therabion Sa Laboratoires | Oligo-elements actives, leur procede de preparation et les compositions les renfermant, utiles pour la sante |
US5188738A (en) * | 1990-08-06 | 1993-02-23 | Steven Kaali | Alternating current supplied electrically conductive method and system for treatment of blood and/or other body fluids and/or synthetic fluids with electric forces |
WO1992018136A1 (en) * | 1991-04-19 | 1992-10-29 | Biotime, Inc. | Blood substitutes and organ preservative solutions |
Non-Patent Citations (1)
Title |
---|
See also references of EP0633027A4 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000078349A1 (fr) * | 1999-06-18 | 2000-12-28 | Pascal Berdal | Procede pour l'obtention de produits ayant des effets benefiques |
FR2800575A1 (fr) * | 1999-11-08 | 2001-05-11 | Pascal Berdal | Procede pour preparer des aliments et des complements alimentaires ayant des effets sur la sante |
WO2005014019A1 (fr) * | 2003-08-07 | 2005-02-17 | Gennadij Alexandrovich Markov | Composition therapeutique et prophylactique de markov |
Also Published As
Publication number | Publication date |
---|---|
DE69331005D1 (de) | 2001-11-29 |
JPH07502764A (ja) | 1995-03-23 |
PT633027E (pt) | 2002-03-28 |
KR100301340B1 (ko) | 2001-10-22 |
DK0633027T3 (da) | 2001-12-10 |
ES2164668T3 (es) | 2002-03-01 |
DE69331005T2 (de) | 2002-06-06 |
KR940703679A (ko) | 1994-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Howatson et al. | Virus-like bodies in a transplantable mouse plasma cell tumour | |
WO1997028776A1 (fr) | Medicament et procede d'action medicamenteuse sur l'organisme | |
WO1994009797A1 (en) | Compound for the biological stimulation and correction of the phenotype of an organism and a process for producing the same | |
Randall et al. | Special techniques | |
CN105454667A (zh) | 一种可替代抗生素的饲料添加剂及其制备方法 | |
EP0633027A4 (en) | COMPOUND FOR BIOLOGICAL STIMULATION AND CORRECTION OF THE PHENOTYPE OF AN ORGANISM AND PROCESS FOR PRODUCING THE SAME. | |
Hart | Carcinoma complicated by proximal motor neuropathy due to vitamin-B deficiency | |
JPH013127A (ja) | 水棲生物の疾病の予防及び治療法 | |
US3551566A (en) | Fish disease treating composition and method of using same | |
JP5472752B2 (ja) | 殺菌用水溶液の製造方法、アルコール殺菌液及びその製造方法 | |
McNaught et al. | Effects of Sulfanilamide, Phenothiazine and Thionol in Experimental Trichinosis. | |
RU2093182C1 (ru) | Состав для биологической стимуляции организма | |
Mitsui et al. | Effective treatment of bladder tumor-bearing mice by direct delivery of bleomycin using electrochemotherapy | |
RU2445967C2 (ru) | Способ профилактики и лечения желудочно-кишечных заболеваний телят | |
RU2067860C1 (ru) | Способ лечения постнатальной гипотрофии поросят | |
DE1946664C3 (de) | Mittel zum Behandeln von durch pathogene Mikroorganismen verursachte Fischkrankheiten | |
RU2093180C1 (ru) | Состав для биологической стимуляции организма и способ его обработки | |
RU2013949C1 (ru) | Средство для лечения некроза плавников рыб | |
RU2230559C1 (ru) | Способ стимулирования колониеобразования кроветворных клеток-предшественников в селезенке при облучении животных | |
Sloan | SODIUM BICARBONATE VS. CANCER | |
RU2080110C1 (ru) | Препарат для лечения острых желудочно-кишечных болезней новорожденных телят и способ его применения | |
RU2117485C1 (ru) | Средство для профилактики и лечения пневмоэнтеритов поросят - препарат "живая кровь" | |
RU2021809C1 (ru) | Вещество, обладающее противоопухолевым действием | |
RU2166945C1 (ru) | Радиосенсибилизирующее вещество для лечения онкологических заболеваний | |
SU141449A1 (ru) | Способ лечени болезней молодн ка сельскохоз йственных животных и птицы, св занных с расстройством пищеварени и питани |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
ENP | Entry into the national phase |
Ref document number: 1994 245000 Country of ref document: US Date of ref document: 19940621 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2127114 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019940702303 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1993919734 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
CFP | Corrected version of a pamphlet front page |
Free format text: UNDER INID NUMBER (30)"PRIORITY DATA",REPLACE "920215" BY "930215" |
|
CFP | Corrected version of a pamphlet front page |
Free format text: ABSTRACT IN ENGLISH REPLACED BY CORRECTED ABSTRACT |
|
WWP | Wipo information: published in national office |
Ref document number: 1993919734 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1993919734 Country of ref document: EP |